Skip to content

ARROWHEAD PHARMACEUTICALS, INC.: 10-Q filed 2020-08-05

What ARROWHEAD PHARMACEUTICALS, INC. reported in its quarterly report filed 2020-08-05 (fiscal Q3 2020): 45 published measures, 122 facts as tagged in accession 0001564590-20-036812.

This filing

Form
10-Q (quarterly report)
Filed
2020-08-05
Fiscal period
fiscal Q3 2020
Accession
0001564590-20-036812 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARROWHEAD PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-06-30555,728,072USD
At 2019-09-30349,845,437USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-06-30493,140,393USD
At 2019-09-30244,591,440USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-06-30219,322,617USD
At 2019-09-30221,804,128USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-13,611,213USD91
2019-10-01 to 2020-06-30-36,120,511USD274
2019-04-01 to 2019-06-3020,335,708USD91
2018-10-01 to 2019-06-3056,269,944USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-10-01 to 2020-06-30-84,541,545USD274
2018-10-01 to 2019-06-30159,225,017USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-10-01 to 2020-06-3010,067,360USD274
2018-10-01 to 2019-06-304,170,285USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2020-04-01 to 2020-06-3027,375,778USD91
2019-10-01 to 2020-06-3080,359,211USD274
2019-04-01 to 2019-06-3042,696,636USD91
2018-10-01 to 2019-06-30125,502,807USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-10-01 to 2020-06-30256,943,397USD274
2018-10-01 to 2019-06-3064,548,584USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-10-01 to 2020-06-30-174,883,363USD274
2018-10-01 to 2019-06-30-64,575,067USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-06-30-455,411,478USD
At 2019-09-30-419,290,967USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2020-04-01 to 2020-06-30101,843,436shares91
2019-10-01 to 2020-06-30100,184,216shares274
2019-04-01 to 2019-06-3094,935,471shares91
2018-10-01 to 2019-06-3093,364,102shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2020-04-01 to 2020-06-30101,843,436shares91
2019-10-01 to 2020-06-30100,184,216shares274
2019-04-01 to 2019-06-3098,884,744shares91
2018-10-01 to 2019-06-3097,814,019shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-0.13USD/shares91
2019-10-01 to 2020-06-30-0.36USD/shares274
2019-04-01 to 2019-06-300.21USD/shares91
2018-10-01 to 2019-06-300.6USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-0.13USD/shares91
2019-10-01 to 2020-06-30-0.36USD/shares274
2019-04-01 to 2019-06-300.21USD/shares91
2018-10-01 to 2019-06-300.58USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-06-3030,389,707USD
At 2019-09-3023,214,899USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-10-01 to 2020-06-3027,509,663USD274
2018-10-01 to 2019-06-307,276,875USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-15,945,862USD91
2019-10-01 to 2020-06-30-43,039,711USD274
2019-04-01 to 2019-06-3018,595,749USD91
2018-10-01 to 2019-06-3051,552,585USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-06-30315,232,854USD
At 2019-09-30265,246,817USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-06-3042,783,141USD
At 2019-09-3097,070,679USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-06-304,073,869USD
At 2019-09-307,649,921USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2020-06-3015,788,258USD
At 2019-09-3017,063,580USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-06-3021,692,564USD
At 2019-09-30661,361USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-04-01 to 2020-06-3043,321,640USD91
2019-10-01 to 2020-06-30123,398,922USD274
2019-04-01 to 2019-06-3024,100,887USD91
2018-10-01 to 2019-06-3073,950,222USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-06-30102,250,872shares
At 2019-09-3095,506,271shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2020-06-30-175,219USD
At 2019-09-30-391,624USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2020-06-30492,585,205USD
At 2020-03-31493,563,470USD
At 2019-09-30244,036,252USD
At 2019-06-30225,670,040USD
At 2019-03-31200,640,237USD
At 2018-09-3095,241,001USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-06-3016,522,013USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-06-3021,371,677USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2020-06-3045,353,643USD
At 2019-09-3035,296,550USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-06-3014,963,936USD
At 2019-09-3012,081,651USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-06-30265,359USD
At 2019-09-30144,148USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-06-309,414,696USD
At 2019-09-306,504,729USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2020-06-3026,274,362USD
At 2019-09-3077,769,629USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-13,611,213USD91
2019-10-01 to 2020-06-30-36,120,511USD274
2019-04-01 to 2019-06-3020,335,708USD91
2018-10-01 to 2019-06-3056,269,944USD273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-13,611,213USD91
2019-10-01 to 2020-06-30-36,120,511USD274
2019-04-01 to 2019-06-3020,335,708USD91
2018-10-01 to 2019-06-3056,269,944USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-13,157,318USD91
2019-10-01 to 2020-06-30-35,904,106USD274
2019-04-01 to 2019-06-3020,304,536USD91
2018-10-01 to 2019-06-3056,188,430USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-3010,748,506USD91
2019-10-01 to 2020-06-3038,008,836USD274
2019-04-01 to 2019-06-304,809,177USD91
2018-10-01 to 2019-06-3016,287,841USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2020-04-01 to 2020-06-301,111,293USD91
2019-10-01 to 2020-06-302,892,551USD274
2019-04-01 to 2019-06-30578,342USD91
2018-10-01 to 2019-06-302,081,447USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2020-04-01 to 2020-06-30425,107USD91
2019-10-01 to 2020-06-301,275,322USD274
2019-04-01 to 2019-06-30425,107USD91
2018-10-01 to 2019-06-301,275,322USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-04-01 to 2020-06-302,334,649USD91
2019-10-01 to 2020-06-306,919,200USD274
2019-04-01 to 2019-06-301,739,959USD91
2018-10-01 to 2019-06-304,717,359USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2018-10-01 to 2019-06-3027,437USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2019-10-01 to 2020-06-30250,478,974USD274
2019-12-01 to 2019-12-31250,500,000USD31
2018-10-01 to 2019-06-3060,521,729USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2020-04-01 to 2020-06-30500,000USD91
2019-10-01 to 2020-06-301,100,000USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-10-01 to 2020-06-3021,031,203USD274
2018-10-01 to 2019-06-301,716,736USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2019-10-01 to 2020-06-30-3,576,053USD274
2018-10-01 to 2019-06-301,824,146USD273

Inspect the source

Entity
ARROWHEAD PHARMACEUTICALS, INC. / CIK 0000879407
Captured
2026-09-20T05:01:27.924Z
SEC response SHA-256
df8855dae0055b71bd49c85d7ebc47f72ea6d71536d6bfd857bed2fe95364863

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000879407.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))